Osaic Holdings’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$129K Buy
8,806
+4,626
+111% +$61.1K ﹤0.01% 4756
2026
Q1
$57.6K Buy
4,180
+182
+5% +$2.74K ﹤0.01% 5103
2025
Q4
$72.1K Buy
3,998
+210
+6% +$3.77K ﹤0.01% 4977
2025
Q3
$63.3K Buy
3,788
+232
+7% +$3.65K ﹤0.01% 5156
2025
Q2
$57.2K Sell
3,556
-696
-16% -$12.4K ﹤0.01% 4956
2025
Q1
$82.6K Sell
4,252
-39,744
-90% -$836K ﹤0.01% 4322
2024
Q4
$969K Buy
43,996
+10,857
+33% +$209K ﹤0.01% 2222
2024
Q3
$558K Buy
33,139
+1,701
+5% +$25.2K ﹤0.01% 2768
2024
Q2
$376K Buy
31,438
+99
+0.3% +$1.11K ﹤0.01% 3007
2024
Q1
$347K Sell
31,339
-6,544
-17% -$66.8K ﹤0.01% 3235
2023
Q4
$328K Buy
37,883
+35,715
+1,647% +$278K ﹤0.01% 3523
2023
Q3
$16.6K Buy
+2,168
New +$16.3K ﹤0.01% 5646

Other funds holding CLBT

Osaic Holdings's CLBT Position: Q2 2026 in Review

Osaic Holdings increased its Cellebrite (CLBT) stake by 111% in Q2 2026, buying an estimated $61.1K and bringing the position to 8,806 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #4756.

Osaic Holdings first reported a position in CLBT in Q3 2023 and has held it in 12 quarters since. The position peaked at $969K in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Osaic Holdings held 8,806 shares of Cellebrite worth $129K as of Q2 2026.
  • Osaic Holdings bought 4,626 Cellebrite shares in Q2 2026, an estimated $61.1K.
  • Cellebrite made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4756 holding.
  • Osaic Holdings first reported a position in Cellebrite in Q3 2023 and has held it in 12 quarters since.
  • Osaic Holdings's Cellebrite position peaked at $969K in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.